Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects and adverse effects of opioids: role of pharmacokinetic and pharmacogenetic heterogeneity
2009-013022-16Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Aug 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of morphine, oxycodone, fentanyl and hydromorphone in cancer pain (4 arms), sponsored by Erasmus MC. Primary endpoint: Achievement of pain control. Started Aug 2009; status: active.
02
Drugs
morphineoxycodonefentanylhydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2009-013022-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013022-16.